Seattle Genetics (SGEN) Reports Q1 Loss of $0.73

April 26, 2018 4:05 PM EDT

Seattle Genetics (NASDAQ: SGEN) reported Q1 EPS of ($0.73), versus ($0.42) reported last year. Revenue for the quarter came in at $140.59 million, versus $109.13 million reported last year.

For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings